Clinical Trial Update: An Early Phase 2 Clinical Study of KSP-0243 [Phase 2]

View source ↗

Summary

An early Phase 2 study of KSP-0243 for ulcerative colitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• KSP-0243

Snippet

Sponsor: Kissei Pharmaceutical Co., Ltd. | Conditions: Colitis, Ulcerative | Phase 2 | Status: COMPLETED